Solventum Corporation (BST:KB7)

Market Cap	11.32B -8.0%
Revenue (ttm)	7.09B +0.9%
Net Income	1.33B +224.8%
EPS	7.56 +221.7%
Shares Out	n/a
PE Ratio	8.54
Forward PE	11.82
Dividend	n/a
Ex-Dividend Date	n/a

Volume	21
Average Volume	68
Open	64.00
Previous Close	65.20
Day's Range	62.00 - 65.00
52-Week Range	55.40 - 79.50
Beta	n/a
RSI	51.68
Earnings Date	Feb 26, 2026

About Solventum

Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates in three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions for negative pressure wound therapy, advanced wound dressings, advanced skin care, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical e...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 2023
• Employees: 22,000
• Stock Exchange: Stuttgart Stock Exchange
• Ticker Symbol: KB7

Financial Performance

In 2025, Solventum's revenue was $8.33 billion, an increase of 0.86% compared to the previous year's $8.25 billion. Earnings were $1.56 billion, an increase of 224.84%.

Financial numbers in USD